Labshake search
Citations for Stemcell Technologies :
1 - 50 of 1190 citations for trans 2 2 4 Methoxyphenyl 2 oxoethyl cyclohexane 1 carboxylic acid since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2024Quote: ... SH-SY5Y cells were counted and seeded at a density of 10.4 × 103 cells/cm2 in differentiation media (Neurobasal medium, 2% B27 supplement, 1% GlutaMAX, and 10 μM of all-trans retinoic acid [STEMCELL Technologies]). Differentiation media was replaced every other day until day 9 post-seeding ...
-
bioRxiv - Microbiology 2023Quote: ... 2 µl of 2% rat serum (Stemcell technologies) was added to each well for 15 minutes at room temperature and proceeded to further staining without a washing step.
-
bioRxiv - Cell Biology 2023Quote: ... with the addition of 1 μg/L of human interleukin 2 (IL-2, STEMCELL Technologies Inc., USA).
-
bioRxiv - Bioengineering 2021Quote: ... then 1 µM all-trans retinoic acid (RA, STEMCELL Technologies, 72262) and 100ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2 ...
-
Arc mediates intercellular synaptic plasticity via IRSp53-dependent extracellular vesicle biogenesisbioRxiv - Neuroscience 2024Quote: ... 2% SM1 (StemCell Technologies), 500 µM L-Glutamine ...
-
bioRxiv - Bioengineering 2021Quote: ... and then 1 µM all-trans retinoic acid (RA, STEMCELL Technologies, 72262) and 100ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2 ...
-
bioRxiv - Developmental Biology 2021Quote: ... Definitive endoderm cells are then differentiated into anterior ventral foregut endoderm (Stage 2) using dual SMAD inhibition for 2 days with 2 µM Dorsomorphin (STEMCELL Technologies, cat#72102) and 10 µM SB431542 (STEMCELL Technologies ...
-
bioRxiv - Biophysics 2023Quote: ... with the addition of Human Recombinant Interleukin 2 (IL-2, STEMCELL Technologies Inc., USA).
-
bioRxiv - Neuroscience 2021Quote: ... 2 µM XAV939 (STEMCELL Technologies), 10 µM SB431542 hydrate and 2 µg/mL doxycycline hyclate (Sigma) ...
-
bioRxiv - Pathology 2022Quote: ... 2 µM CHIR99021 (StemCell Technologies), and 10 ng/mL Recombinant Human BMP-7(Peprotech) ...
-
bioRxiv - Neuroscience 2023Quote: ... IWP-2 (STEMCELL Technologies, 72124), RA (Sigma ...
-
bioRxiv - Neuroscience 2024Quote: ... 2% SM1 (05711, STEMCell Technologies), 1% N2 (07152 ...
-
bioRxiv - Bioengineering 2023Quote: ... (StemCell Technologies, #129830-38-2) in mTeSR-1 media ...
-
bioRxiv - Cell Biology 2022Quote: ... 2% SM1 (Stem Cell Technologies), 15mM HEPES (Gibco) ...
-
bioRxiv - Bioengineering 2023Quote: ... (StemCell Technologies, #129830-38-2) in mTeSR-1 media ...
-
bioRxiv - Developmental Biology 2024Quote: ... 2 µM SB431542 (StemCell Technologies), 1 µM DMH1 (Tocris Bioscience) ...
-
bioRxiv - Neuroscience 2024Quote: ... 2 μM DMH1 (StemCell Technologies), and 2 μM SB431542 (Stemgent ...
-
bioRxiv - Neuroscience 2024Quote: ... and 2% SM1 (StemCell Technologies). The cells were then plated on coverslips (Carolina ...
-
bioRxiv - Neuroscience 2024Quote: ... 2 µM Cyclopamine (StemCell Technologies), 2 µg/mL Heparin ...
-
bioRxiv - Neuroscience 2024Quote: ... DMH1 (STEMCELL Technologies; 2 µM), and XAV939 (STEMCELL Technologies ...
-
bioRxiv - Neuroscience 2020Quote: ... Medium was refreshed every 2-3 days and cells were passaged 1-2 times per week using an enzyme-free reagent (ReLeSR, Stem Cell Technologies). For autophagy induction cells were treated with 200 µM Rapamycin (ChemCruz ...
-
Safety and efficacy of C9ORF72-repeat RNA nuclear export inhibition in amyotrophic lateral sclerosisbioRxiv - Systems Biology 2021Quote: ... All-Trans Retinoic Acid 0.1 µM (RA; StemCell Technologies) and Purmorphamine 0.5 µM (PMN ...
-
bioRxiv - Physiology 2024Quote: ... and 0.1 μM all-trans retinoic acid (STEMCELL Technologies). Media was substituted daily until podocyte maturation on day 12 ...
-
bioRxiv - Bioengineering 2024Quote: ... 0.24 mM all-trans retinoic acid (Stem Cell Technologies), 0.5 mM PD173074 (Tocris ...
-
bioRxiv - Physiology 2024Quote: ... and N2B27 supplemented with 2 ng/ml Activin A and 2 µg/ml Heparin (STEMCELL Technologies) for 5 days ...
-
bioRxiv - Genomics 2024Quote: ... and N2B27 supplemented with 2 ng/ml Activin A and 2 µg/ml Heparin (STEMCELL Technologies) for 5 days ...
-
bioRxiv - Cancer Biology 2024Quote: ... Common Rule (Category 4) or 2) de-identified donor leukapheresis products obtained from StemCell Technologies. CD3+ T-cell populations were isolated using RosetteSep Human T Cell Enrichment Cocktails (Stemcell Technologies ...
-
bioRxiv - Cancer Biology 2024Quote: ... Common Rule (Category 4) or 2) de-identified donor leukapheresis products obtained from StemCell Technologies. CD3+ T-cell populations were isolated using EasySep Human T Cell Isolation Kit (StemCell Technologies ...
-
bioRxiv - Neuroscience 2023Quote: ... Each plate was then split 1:2 using ReLeSR (StemCell Technologies), with half of the cells used for DNA extraction for Sanger sequencing ...
-
bioRxiv - Bioengineering 2021Quote: ... 2 μg/ml Heparin (STEMCELL Technologies), 20 ng/ml bFGF (Millipore) ...
-
bioRxiv - Cancer Biology 2020Quote: ... 2 μg/ml heparin (StemCell Technologies), epidermal growth factor (EGF ...
-
bioRxiv - Neuroscience 2020Quote: ... 2% NeuroCult SM1 supplement (STEMCELL Technologies), 2 mM GlutaMax.
-
bioRxiv - Developmental Biology 2020Quote: ... 10ng/mL FGF-2 (StemCell Technology), and 5nM Rock inhibitor ...
-
bioRxiv - Cancer Biology 2023Quote: ... 2 μg/ml heparin (Stemcell Technologies), 50 units/ml penicillin ...
-
bioRxiv - Neuroscience 2022Quote: ... and 2 µM SB431542 (StemCell Technologies). Cells were maintained in NbM for 6 days after which they were passaged with 1 U/mL Dispase (StemCell Technologies ...
-
bioRxiv - Neuroscience 2023Quote: ... 2% SM1 (Stemcell Technologies, Vancouver, Canada), and 5 μM cytosine β-d-arabinofuranoside (AraC ...
-
bioRxiv - Neuroscience 2023Quote: ... B27 (2%v/v, Stemcell technologies), N2 (0.5%v/v ...
-
bioRxiv - Neuroscience 2024Quote: ... 2% NeuroCult SM1 (Stemcell technologies, 05711), 1% penicillin/streptomycin (Thermo Fisher Scientific ...
-
bioRxiv - Neuroscience 2024Quote: ... and XAV939 (STEMCELL Technologies; 2 µM) were added in NM for 6 days ...
-
bioRxiv - Neuroscience 2024Quote: ... 2% NeuroCult SM1 (Stemcell technologies, 05711), 2% HyClone™ Fetal Bovine Serum (Thermo Fisher Scientific ...
-
bioRxiv - Developmental Biology 2024Quote: ... 2 μM CHIR99021 (STEMCELL Technologies, 72054), 0.5 μM A83-01 ...
-
bioRxiv - Cell Biology 2024Quote: ... 2% PB plasma (STEMCELL Technologies, 70039), 10 µg/mL insulin (Sigma-Aldrich ...
-
bioRxiv - Developmental Biology 2023Quote: ... differentiating cells were confluent again and split 1:3-1:4 into Step 2 differentiation medium: BrainPhys Neuronal Medium (STEMCELL Technologies, cat# 05790), 1X N2 ...
-
bioRxiv - Immunology 2024Quote: ... were differentiated into TH2 T cell subtype by incubation with specific supplement for TH2 differentiation (mouse IL-2, mouse IL-4 and rat anti mouse IFNγ with 1:100 dilution (STEMCELL Technologies)) and incubated for 3 days on plates coated with aCD3 and aCD28 antibodies ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with 10 ng μL-1 recombinant human IL-2 (StemCell Technologies) and activated with the ImmunoCult Human CD3/CD28 T Cell Activator (StemCell Technologies) ...
-
bioRxiv - Neuroscience 2024Quote: ... Cells were passaged 1-2 times per week with ReLeSR (STEMCELL Technologies) when they reached 80-90% confluence ...
-
bioRxiv - Genomics 2024Quote: ... cells were resuspended with 1-2 mL Dispase (Stem Cell Technologies, 07923) and 200 µL 1mg/mL DNase I (Stem Cell Technologies ...
-
bioRxiv - Neuroscience 2024Quote: ... and routinely split 1-2 times a week with ReLeSR (STEMCELL Technologies) without ROCKi (Y-27632 ...
-
bioRxiv - Genomics 2020Quote: ... with 2 mM L-Glutamine (Stemcell Technologies), 1x 2-Mercaptoethanol (Millipore) ...
-
bioRxiv - Neuroscience 2021Quote: ... and 2 µM XAV939 (StemCell Technologies, 72674). TPM was changed every day from day 3 to day 7 ...